Itraconazole
NDC 16571-245, Itraconazole, capsule, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-245
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205724
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-245 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ITRACONAZOLE100 mg/1
Pharmacologic classes
Azole Antifungal [EPC]; Azoles [CS]; Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-245-03 | 16571024503 | 30 CAPSULE in 1 BOTTLE (16571-245-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6df5ff94-47ba-4881-abb4-b321e35a6955NADAC price for package 16571024503
GET /v1/drugs/nadac/16571024503
Use it
Look up 16571-245 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-245 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-245. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.